Fitzsimmons WE - Search Results

1

Cortical blindness: a rare complication of cyclosporine therapy.

Ghalie R, Fitzsimmons WE, Bennett D, Kaizer H. Ghalie R, et al. Among authors: fitzsimmons we. Bone Marrow Transplant. 1990 Aug;6(2):147-9. Bone Marrow Transplant. 1990. PMID: 2207451 Review.

2

Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.

Ghalie R, Fitzsimmons WE, Weinstein A, Manson S, Kaizer H. Ghalie R, et al. Among authors: fitzsimmons we. Ann Pharmacother. 1994 Mar;28(3):379-83. doi: 10.1177/106002809402800315. Ann Pharmacother. 1994. PMID: 8193430

3

Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation.

Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H. Ghalie R, et al. Am J Hematol. 1993 Apr;42(4):350-3. doi: 10.1002/ajh.2830420404. Am J Hematol. 1993. PMID: 8493984

4

The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity.

Fitzsimmons WE, Ghalie R, Kaizer H. Fitzsimmons WE, et al. Cancer Chemother Pharmacol. 1990;27(3):226-8. doi: 10.1007/BF00685717. Cancer Chemother Pharmacol. 1990. PMID: 2265459

5

Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.

Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR. Horowitz MM, et al. Among authors: fitzsimmons we. Biol Blood Marrow Transplant. 1999;5(3):180-6. doi: 10.1053/bbmt.1999.v5.pm10392964. Biol Blood Marrow Transplant. 1999. PMID: 10392964 Free article. Clinical Trial.

6

Anticonvulsants and busulfan.

Fitzsimmons WE, Ghalie R, Kaizer H. Fitzsimmons WE, et al. Ann Intern Med. 1990 Apr 1;112(7):552-3. doi: 10.7326/0003-4819-112-7-552_2. Ann Intern Med. 1990. PMID: 2316947 No abstract available.

7

Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD.

Espino G, Denney J, Furlong T, Fitzsimmons W, Nash RA. Espino G, et al. Bone Marrow Transplant. 2001 Dec;28(12):1097-103. doi: 10.1038/sj.bmt.1703304. Bone Marrow Transplant. 2001. PMID: 11803349 Clinical Trial.

8

Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.

Yu C, Storb R, Deeg HJ, Graham TC, Scheuning FG, Huss R, Seidel K, Fitzsimmons WE. Yu C, et al. Among authors: fitzsimmons we. Bone Marrow Transplant. 1996 Apr;17(4):649-53. Bone Marrow Transplant. 1996. PMID: 8722370

9

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.

Wingard JR, Nash RA, Ratanatharathorn V, Fay JW, Klein JL, Przepiorka D, Maher RM, Devine SM, Boswell G, Bekersky I, Fitzsimmons W. Wingard JR, et al. Bone Marrow Transplant. 1997 Jul;20(1):49-51. doi: 10.1038/sj.bmt.1700839. Bone Marrow Transplant. 1997. PMID: 9232256 Clinical Trial.

10

Tacrolimus pharmacokinetics in BMT patients.

Boswell GW, Bekersky I, Fay J, Wingard J, Antin J, Weisdorf D, Maher R, Fitzsimmons W, Nash R. Boswell GW, et al. Bone Marrow Transplant. 1998 Jan;21(1):23-8. doi: 10.1038/sj.bmt.1701054. Bone Marrow Transplant. 1998. PMID: 9486490 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page